Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07GZL
|
|||
| Former ID |
DIB010982
|
|||
| Drug Name |
R-701
|
|||
| Indication | Overactive bladder [ICD-11: GC50.0; ICD-10: N32.8] | Discontinued in Phase 1 | [1] | |
| Company |
Roche Holding AG
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GPCR unspecific (GPCR) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017119) | |||
| REF 2 | R 701 Roche discontinued, USA (overactive bladder), R & D Focus Drug News. February 23, 2004 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.